Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | 0.00% | -5.00% | -28.75% |
16/04 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
27/03 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-28.75% | 73.06L | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- ATX Stock
- News Amplia Therapeutics Limited
- Amplia Therapeutics Secures Approval for Dose Escalation Stage of Pancreatic Cancer Trial